期刊文献+

胃肠道间质瘤的治疗现状 被引量:1

Current Therapy Status of Gastrointestinal Stromal Tumor
下载PDF
导出
摘要 胃肠道间质瘤是一类起源于胃肠道间叶组织的肿瘤。目前治疗方法主要包括手术治疗和药物治疗。在药物治疗中,伊马替尼治疗不可切除/转移/复发GIST疗效显著,使得伊马替尼辅助治疗的应用日益受到重视。 Gastrointestinal stromaI tumor (GIST) is a tumor originated in the gastrointestinal tract mesenchymal tissue. Current treatment includes surgery and drug therapy. In drug treatment, imatinib has significant therapeutic effect in the treatment of unresectable and/or transfer/recurrence of GIST, so imatibib has received more attention for neoadjuvant therapy applications.
作者 尹承倩
出处 《药品评价》 CAS 2012年第24期39-41,共3页 Drug Evaluation
关键词 胃肠道间质瘤 手术切除 伊马替尼 靶向治疗 Gastrointestinal stromal tumor Surgical resection Imatinib Targeted therapy
  • 相关文献

参考文献12

  • 1Joensuu I-I, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol, 2002, 3: 655-664.
  • 2李金丽,王仁本,于金明.胃肠间质瘤诊治进展[J].中华肿瘤防治杂志,2006,13(20):1591-1594. 被引量:16
  • 3崔淑兰,陈垦.胃泌素瘤的诊断和治疗[J].医学综述,1998,4(1):42-45. 被引量:1
  • 4马良,钟鉴宏,黎乐群.伊马替尼辅助治疗胃肠间质瘤所面临的问题[J].现代肿瘤医学,2011,19(10):2101-2104. 被引量:1
  • 5DeMatteo R, Owzar K, Maki R, et al. Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor(GIST): North American Intergroup Phase III trial ACOSOG Z9001. 2007.
  • 6ASCO Annual Meeting. Abstract 10079. Bonvalot S, Eldweny H, Pechoux CL, et al. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era[J]. Ann Surg Oncol, 2006, 13(12): 1596-1603.
  • 7Dematteo RP, Heinrich MC, EI-Rifai WM, et al. Clinical management of gastrointestinal stromal tumors: before and after STI571 [J]. Hum Pathol, 2002, 33: 466-477.
  • 8Nilsson B, Sjolund K, Kindblom LG, et al. Adjuvant imatinib treat-ment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)[J]. Br J Cancer, 2007, 96: 1656-1658.
  • 9Guilhot F. Indications for imatinib mesylate therapy and clinical management[J]. Oncologist, 2004, 9(3): 271-281.
  • 10Verweij J, Casali P G, Zalcberg J, et al. Progression-flee survival in gastrointestinal stromal tumour s with high-dose imatinib: randomised trial(9440)[ J]. Lancet, 2004, 364(9440): 1127-1134.

二级参考文献61

  • 1廖松林,高冬霞.胃肠道间质瘤的进展[J].实用医院临床杂志,2004,1(3):13-14. 被引量:15
  • 2白月奎,邵永孚,石素胜,高燕宁,孙耘田,程书钧,刘秀云.胃肠道间质瘤预后多因素分析[J].中华肿瘤杂志,2005,27(10):598-601. 被引量:22
  • 3孙现军,徐忠法.胃肠道间质瘤的诊断和治疗[J].中华肿瘤防治杂志,2006,13(7). 被引量:5
  • 4詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 5Corless CL,Heinrich MC.Molecular pathobiology of gastrointestinal stromal sarcomas[J].Annu Rev Pathol,2008,3:557-586.
  • 6Nilsson B,Bumming P,Meis-Kindblom JM,et al.Gastrointestinal stromal tumors:the incidence,prevalence,clinical course,and prognostication in the preimatinib mesylate era-a population-based study in western Sweden[J].Cancer,2005,103:821-829.
  • 7Lux ML,Rubin BP,Biase TL,et al.KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors[J].Am J Pathol,2000,156:791-795.
  • 8Heinrich MC,Corless CL,Duensing A,et al.PDGFRA activating mutations in gastrointestinal stromal tumors[J].Science,2003,299:708-710.
  • 9DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival[J].Ann Surg,2000,231:51-58.
  • 10Rossi CR,Mocellin S,Mencarelli R,et al.Gastrointestinal stromal tumors:from a surgical to a molecular approach[J].Int J Cancer,2003,107:171-176.

共引文献15

同被引文献9

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部